The drug development process is a complex venture. It requires progress by following parallel, sometimes contrary objectives: Matching pharmaceutical regulatory requirements with the complexities inherent to modern drug compounds while achieving the desired product specifications towards patient friendly drugs. Drug product innovators frequently lack profound expertise in identifying and harnessing the vast potential that modern drug delivery systems may offer to their products in these regards.

MCS bridges this gap in expertise.

We blend drug carrier know-how with a diversified portfolio of specialised drug delivery technologies and complement our expertise by value-added services. Our core competence is the development of tailor-made pre-clinical and clinical formulations. Your respective benefits: Rapid proof-of-concept results or marketable drugs with distinct value-added assets.

From early development through late-phase trials, MCS offers the entire range of integrated product development services you need.